Health : Page 48

Hetero's Nirmacom is world's first generic version of COVID-19 oral drug Paxlovid to receive WHO prequalificat

December 27, 2022 Hetero, India\'s pharmaceutical company, announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate nirmatrelvir.

Leaked documents: Sudden COVID outbreaks show lack of efficacy of Chinese vaccines

December 27, 2022 China\'s sudden COVID-19 outbreaks \"demonstrate a lack of effectiveness of its vaccines\", Tibet Press reported.

China stops publishing daily COVID-19 figures, infections explode, 250m cases in 20 days, 1m in just one city

December 25, 2022 China’s National Health Commission (NHC) stopped publishing daily COVID-19 data amid doubts about their reliability as infections have exploded amid an abrupt easing of tough restrictions.

FDA approves new HIV drug for adults with limited treatment options

December 24, 2022 The U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations.

FDA approves Lunsumio to treat relapsed/refractory follicular lymphoma

December 24, 2022 Roche announced that the U.S. Food and Drug Administration (FDA) has approved Lunsumio (mosunetuzumab-axgb) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy.

Measles cases on the rise in South Africa

December 24, 2022 The National Institute for Communicable Diseases (NICD) announced that measles cases continue to soar across the country.

Valneva makes U.S. regulatory submission for one-shot chikungunya vaccine

December 23, 2022 Valneva has completed rolling submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for its single shot chikungunya vaccine candidate, VLA1553.

Hong Kong's department of health investigates case of mad honey poisoning

December 23, 2022 The Centre for Health Protection (CHP) of the Department of Health is investigating a case of mad honey poisoning.

At least 24 children among 94 dead from Strep A in UK, calls to NHS 111 skyrocketed

December 22, 2022 A further five children have now died across the UK from invasive Strep A disease, according to new figures.

FDA approves Roche’s Actemra for treatment of COVID-19 in hospitalised adults

December 22, 2022 Roche announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalised adult patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Ontario expanding safe use of biosimilars

December 22, 2022 Ontario is joining several other provinces and territories by expanding the use of biosimilar drug treatments for Ontarians.

Researchers developing antibiotics that target multiple-drug-resistant bacteria

December 21, 2022 Researchers have designed and synthesized analogs of a new antibiotic that is effective against multidrug-resistant bacteria, opening a new front in the fight against these infections.